Patent · US Active

Inducible caspases and methods for use

US11718656B2 · kind B2 · utility

0Cited by
29References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 2, 2022
Grant dateAug 8, 2023
Priority date
Expiry dateJun 2, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/22036
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure provides inducible caspase polypeptides, compositions comprising inducible caspase polypeptides and sequences encoding the same, cells modified to express the polypeptides and compositions of the disclosure, as well as methods of making and methods of using same for adoptive cell therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.